Ingevity (NGVT) director receives 328 DSUs in lieu of board fees

Rhea-AI Filing Summary

Ingevity Corp director Francis David Segal reported an acquisition of 328 shares of Common Stock, recorded as a grant or award valued at $72.58 per share. Following this award, his direct holdings increased to 8,612 shares.

According to the footnote, the 328 vested deferred stock units were granted under Segal’s election to receive DSUs instead of quarterly director fees. These DSUs will convert into an equal number of Ingevity common shares when his board service ends, under the company’s deferred compensation and 2025 omnibus incentive plans.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Segal Francis David

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	328	$72.58	$24K

Holdings After Transaction: Common Stock — 8,612 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Director grant size: 328 shares Grant price: $72.58 per share Post-transaction holdings: 8,612 shares

3 metrics

Director grant size 328 shares Grant/award acquisition of Common Stock equivalents

Grant price $72.58 per share Valuation used for the 328-share award

Post-transaction holdings 8,612 shares Total direct Ingevity Common Stock holdings after grant

Key Terms

deferred stock units, Non-Employee Director Deferred Compensation Plan, 2025 Omnibus Incentive Plan, Form 4

4 terms

deferred stock units financial

"Represents vested deferred stock units ("DSUs") granted pursuant to the reporting person's election"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Non-Employee Director Deferred Compensation Plan financial

"upon the reporting person's termination of board service pursuant to the Company's Amended and Restated Non-Employee Director Deferred Compensation Plan"

2025 Omnibus Incentive Plan financial

"pursuant to the Company's Amended and Restated Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan, as amended"

An omnibus incentive plan is a company-wide program that authorizes awards of pay tied to performance and retention—such as stock options, restricted shares, cash bonuses and other rewards—here labeled for the year it was adopted (2025). Investors care because it affects how much ownership can be issued, dilutes existing shareholders, and aligns executives’ and employees’ incentives with company goals, similar to giving team members a stake in the outcome.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 04:21 PM Accepted by SEC EDGAR 07/02/2026 - 04:21 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Segal Francis David

(Last) (First) (Middle)

C/O INGEVITY CORPORATION

4920 O'HEAR AVE, SUITE 400

(Street)

NORTH CHARLESTON SOUTH CAROLINA 29405

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ingevity Corp [ NGVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A		328(1)	A	$72.58	8,612	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents vested deferred stock units ("DSUs") granted pursuant to the reporting person's election to receive DSUs in lieu of quarterly director fees. These DSUs will settle into an equal number of shares of the Company's Common Stock upon the reporting person's termination of board service pursuant to the Company's Amended and Restated Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan, as amended.

Remarks:

	Francis David Segal By: Mavis G. Huger as Attorney-in-Fact	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Ingevity (NGVT) director Francis David Segal report?

Francis David Segal reported receiving 328 vested deferred stock units, treated as Common Stock, at $72.58 per share. This grant is compensation-related rather than an open-market purchase, and it increased his direct holdings to 8,612 Ingevity shares.

How many Ingevity (NGVT) shares does Francis David Segal hold after this Form 4?

After the reported grant, Francis David Segal directly holds 8,612 Ingevity Common Stock shares. This total reflects the addition of 328 vested deferred stock units awarded in lieu of quarterly director fees, as disclosed in the Form 4 filing footnote.

At what price were the 328 Ingevity (NGVT) shares recorded in the Form 4?

The 328 reported shares were recorded at a price of $72.58 per share. This figure reflects the valuation used for the grant or award of vested deferred stock units that Segal elected to receive instead of cash director fees.

What are the deferred stock units (DSUs) granted to Ingevity (NGVT) director Segal?

The DSUs are vested deferred stock units granted because Segal chose DSUs instead of quarterly director fees. Each DSU will settle into one share of Ingevity Common Stock when his board service terminates, under the company’s deferred compensation and 2025 omnibus incentive plans.

When will Francis David Segal’s Ingevity (NGVT) DSUs convert into common shares?

The DSUs will convert into an equal number of Ingevity Common Stock shares upon Segal’s termination of board service. Settlement timing is tied specifically to when his service as a director ends, according to the company’s non-employee director deferred compensation plan.